Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Form 8.3 - [JTC PLC - 06 11 2025] - (CGAML)
-
Grabar Law Office Investigates Claims on Behalf of Shareholders of Maison Solutions Inc. (NASDAQ: MSS) as Securities Fraud Class Action Survives Motion to Dismiss and Approaches Settlement
-
Form 8.3 - [IQE PLC - 06 11 2025] - (CGAML)
-
Virbac : Declaration of the number of shares and voting rights 10/2025
-
Form 8.3 - [IDOX PLC - 06 11 2025] - (CGWL)
-
Form 8.3 - Avadel Pharmaceuticals plc
-
Danske Bank A/S, transactions by persons discharging managerial responsibilities
-
Kinetic Celebrates 2 Years of Teaching Safe, Smart Streaming Education
-
red violet Named to TIME’s America’s Growth Leaders of 2026 List
-
Davis Commodities Evaluates Premium Nutrition Vertical Within USD 97 Billion Specialty Food Ingredients Market
-
Form 8.3 - Dalata Hotel Group plc
-
LHV Group's own share acquisition transactions
-
Quantum Leap Energy LLC Announces Private Placement of Convertible Notes Led by American Ventures LLC
-
Purpose Investments Wins Awards for Investment Excellence
-
Thai vocational education representatives visit Guangxi Financial Vocational College, jointly discussing a new blueprint for vocational education
-
GBank Financial Holdings Inc. and GBank Appoint Hilary R. Sledge-Sarnor as Executive Vice President, General Counsel, and Corporate Secretary
-
Jet.AI and Consensus Core Complete Second Milestone of Canadian Hyperscale Data Center Project
-
Edible Garden Schedules Third Quarter 2025 Financial Results and Business Update Conference Call
-
Form 8.3 - IDOX plc - Octopus Investments
-
Easy Environmental Solutions Begins Trading Under New Ticker Symbol “EZES”
-
Just Published! A New Book that Promises Inspiration to Transform Lives with Love and Kindness: Kennedy's Inspiring Story
-
Just Published! A New Book that Promises Inspiration to Transform Lives with Love and Kindness: Kennedy's Inspiring Story
-
Xilio Therapeutics Announces Late-Breaking Phase 2 Data for Vilastobart in Patients with MSS mCRC and High Plasma Tumor Mutational Burden at Society for Immunotherapy of Cancer (SITC) 40th Annual Meet
-
AB Amber Grid Operating Results for 9 months of 2025
-
Lincoln Tech to Expand Presence in Texas with New Rowlett Campus
-
Strategy Overview Named Champion of PitchIT Competition at IT Nation Connect 2025
-
Werewolf Therapeutics Presents Data Expanding Its PREDATOR® Platform at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
-
Changes in Nokia Corporation's own shares
-
H/Advisors Abernathy Named Private Equity Wire’s U.S. PR & Communications Firm of the Year in 2025 for Second Consecutive Year
-
ACCA Re-elects Three North American Members to the Global Accounting Body’s Council
-
Bluum Unveils 17,000 Sq Ft Phoenix Facility
-
RFN's SX-E60: A New Era of Control in Electric Off-Roading Explored at EICMA Roundtable
-
Xilio Therapeutics Highlights Portfolio of Differentiated Masked Immunotherapies at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting
-
Punchcut Appoints Akshat Srivastava Director of Design Engineering
-
Legrand Acquires Avtron Power Solutions, a Global Provider of Load Banks & Power Quality Solutions
-
IO Biotech Presents Pre-Clinical Data Highlighting the Potential of Additional Therapeutic Cancer Vaccine Candidates at the 2025 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
-
Trained Therapeutix Demonstrates RIDE-001 Trains Myeloid Cells for Anti-Tumor Immune Response in Preclinical Data Presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
-
Nurix Therapeutics Presents New Translational Data from First-in-Human Clinical Trial of Oral CBL-B Inhibitor NX-1607 Demonstrating Immune Activation and Tumor Microenvironment Remodeling
-
Gold Prices Continue to Fluctuate at High Levels, Blue Hat's Gold Assets Deliver Significant Returns
-
BioAtla’s Mecbotamab Vedotin (Mec-V), an AXL-targeting ADC, Demonstrates a Median Overall Survival (OS) of 21.5 months in Subtypes of Refractory Soft Tissue Sarcomas
-
Wrap and LETAC Lead Policy Development for Human Centered Non-Lethal Integration of Humanoid Robotics in Public Safety
-
BioAge Labs to Present at Jefferies Global Healthcare Conference in London
-
Precision Optics Announces Product Development Agreement to Deliver Next-Generation Augmented Reality Sub-Systems for Fighter Pilots
-
Nouscom Presents New Positive Phase 1/2b data of NOUS-209 at SITC 2025, Supporting Plans to Initiate Registration-Enabling Study for Cancer Interception in Lynch Syndrome Carriers
-
Creative Realities Closes Acquisition of Cineplex Digital Media
-
Trump Media Reports Third Quarter 2025 Results
-
H/Advisors Abernathy Named Private Equity Wire’s U.S. PR & Communications Firm of the Year in 2025 for Second Consecutive Year
-
Flare Therapeutics Presents Correlative Biomarker Analysis from the FX-909 Phase 1A Clinical Study at SITC 2025 40th Anniversary Annual Meeting
-
Wearable Devices Expands into Asia’s Tech Powerhouse: Secures Exclusive Distribution Agreement in South Korea
-
RFN's SX-E60: A New Era of Control in Electric Off-Roading Explored at EICMA Roundtable
